Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Feb 28, 2025 | FY 2024Feb 29, 2024 |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 |
| Selling General And Administration | 73,305 | 458.00 |
| General And Administrative Expense | 73,305 | 458.00 |
| Other Operating Expenses | 11,566 | -- |
| Operating Expense | 84,871 | 458.00 |
| Operating Income | -84,871 | -458.00 |
| EBIT | -84,871 | -458.00 |
| Interest Expense | 563.00 | 0.00 |
| Interest Expense Non Operating | 563.00 | 0.00 |
| Net Interest Income | -563.00 | 0.00 |
| Pretax Income | -85,434 | -458.00 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -85,434 | -458.00 |
| Net Income From Continuing Operation Net Minority Interest | -85,434 | -458.00 |
| Net Income Including Noncontrolling Interests | -85,434 | -458.00 |
| Net Income Common Stockholders | -85,434 | -458.00 |
| Net Income | -85,434 | -458.00 |
| EBITDA | -84,871 | -458.00 |
| Normalized EBITDA | -84,871 | -458.00 |
| Basic EPS | -0.01 | -0.00 |
| Diluted EPS | -0.01 | -0.00 |
| Basic Average Shares | 11.5M | 11.5M |
| Diluted Average Shares | 11.5M | 11.5M |
| Tax Rate For Calcs | 0.00 | 0.00 |
| Normalized Income | -85,434 | -458.00 |
| Diluted NI Availto Com Stockholders | -85,434 | -458.00 |
| Net Income Continuous Operations | -85,434 | -458.00 |
| Net Non Operating Interest Income Expense | -563.00 | 0.00 |
| Other Gand A | 73,305 | 458.00 |
| Total Expenses | 84,871 | 458.00 |
| Line Item | FY 2025Feb 28, 2025 | FY 2024Feb 29, 2024 |
|---|---|---|
| Cash And Cash Equivalents | 221,361 | 0.00 |
| Cash Cash Equivalents And Short Term Investments | 221,361 | 0.00 |
| Cash Financial | 221,361 | 0.00 |
| Prepaid Assets | 10,000 | 0.00 |
| Current Assets | 231,361 | 0.00 |
| Net PPE | 126,865 | 0.00 |
| Total Non Current Assets | 126,865 | 0.00 |
| Total Assets | 358,226 | 0.00 |
| Accounts Payable | 91,317 | 2,351 |
| Payables | 91,317 | 2,351 |
| Payables And Accrued Expenses | 121,873 | 2,351 |
| Current Accrued Expenses | 30,556 | 0.00 |
| Current Liabilities | 121,873 | 2,351 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 121,873 | 2,351 |
| Common Stock | 324,138 | 0.00 |
| Capital Stock | 324,138 | 0.00 |
| Retained Earnings | -87,785 | -2,351 |
| Common Stock Equity | 236,353 | -2,351 |
| Stockholders Equity | 236,353 | -2,351 |
| Total Equity Gross Minority Interest | 236,353 | -2,351 |
| Total Capitalization | 236,353 | -2,351 |
| Net Tangible Assets | 236,353 | -2,351 |
| Tangible Book Value | 236,353 | -2,351 |
| Working Capital | 109,488 | -2,351 |
| Invested Capital | 236,353 | -2,351 |
| Share Issued | 11.5M | 11.5M |
| Ordinary Shares Number | 11.5M | 11.5M |
| Line Item | FY 2025Feb 28, 2025 | FY 2024Feb 29, 2024 |
|---|---|---|
| Operating Cash Flow | -37,777 | 0.00 |
| Cash Flow From Continuing Operating Activities | -37,777 | 0.00 |
| Change In Working Capital | 47,657 | 458.00 |
| Change In Payables And Accrued Expense | 57,657 | 458.00 |
| Capital Expenditure | -65,000 | -- |
| Purchase Of PPE | -65,000 | 0.00 |
| Net PPE Purchase And Sale | -65,000 | 0.00 |
| Investing Cash Flow | -65,000 | 0.00 |
| Cash Flow From Continuing Investing Activities | -65,000 | 0.00 |
| Issuance Of Capital Stock | 324,138 | 0.00 |
| Net Common Stock Issuance | 324,138 | 0.00 |
| Financing Cash Flow | 324,138 | 0.00 |
| Cash Flow From Continuing Financing Activities | 324,138 | 0.00 |
| Changes In Cash | 221,361 | -- |
| Beginning Cash Position | 0.00 | 0.00 |
| End Cash Position | 221,361 | 0.00 |
| Free Cash Flow | -102,777 | 0.00 |
| Change In Prepaid Assets | -10,000 | 0.00 |
| Common Stock Issuance | 324,138 | 0.00 |
| Net Income From Continuing Operations | -85,434 | -458.00 |
| Net Other Investing Changes | -65,000 | -- |